Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease

被引:82
|
作者
Adi, Handoko [1 ]
Young, Paul M. [1 ]
Chan, Hak-Kim [1 ]
Agus, Helen [2 ]
Traini, Daniela [1 ]
机构
[1] Univ Sydney, Adv Drug Delivery Grp, Fac Pharm A15, Sydney, NSW 2006, Australia
[2] Univ Sydney, Fac Sci G08, Sydney, NSW 2006, Australia
关键词
Mannitol; Ciprofloxacin; Dry powder inhaler (DPI); Cystic fibrosis; Antibiotics; Mucolytics; RECOMBINANT HUMAN DNASE; HIGH-DOSE IBUPROFEN; PSEUDOMONAS-AERUGINOSA; N-ACETYLCYSTEINE; LUNG-FUNCTION; MUCUS CLEARANCE; INHALATION; ANTIBIOTICS; SAFETY; INFECTION;
D O I
10.1016/j.ejps.2010.03.020
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to assess the potential of delivering a combination therapy, containing mannitol (a sugar alcohol with osmotic characteristics), and ciprofloxacin hydrochloride (an antibacterial fluoroquinolone), as a dry powder inhaler (DPI) formulation for inhalation. Single and combination powders were produced by spray drying ciprofloxacin and mannitol, from aqueous solution, at different ratios and under controlled conditions, as to obtain similar particle size distributions. Each formulation was characterised using laser diffraction, scanning electron microscopy, differential scanning calorimetry, dynamic vapour sorption, X-ray powder diffraction, and colloidal force microscopy. The in vitro aerosol performance of each formulation was studied using an Aerolizer (R) DPI device and a multi-stage liquid impinger (analysed using high performance liquid chromatography). In addition, a disk diffusion test was performed to assess the in vitro antimicrobial activity of each formulation and starting materials. All formulations had similar particle size distributions, however, the morphology, thermal properties and moisture sorption was dependent on the relative percentages of each component. In general, the combination formulation containing 50% (w/w) mannitol appeared to have the best aerosol performance, good stability and lowest particle cohesion (as measured by colloid probe microscopy). Furthermore, of the formulations tested, mannitol did not appear to alter the effectiveness of the ciprofloxacin antimicrobial activity to Staphylococcus aureus, Pseudomonas aeruginosa and Streptococcus pyogenes. The combination of co-spray-dried mannitol and ciprofloxacin from a DPI is an attractive approach to promote mucous clearance in the respiratory tract while simultaneously treating local chronic infection, such as chronic obstructive pulmonary disease and cystic fibrosis. Crown Copyright (C) 2010 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:239 / 247
页数:9
相关论文
共 50 条
  • [1] Ciprofloxacin dry powder inhaler in cystic fibrosis
    Elborn, J. Stuart
    BMJ OPEN RESPIRATORY RESEARCH, 2016, 3 (01):
  • [2] THE SURFACE ENERGY EFFECT OF CO-SPRAY-DRIED MANNITOL WITH POLYETHYLENE GLYCOL ON THE AEROSOLIZATION PERFORMANCE IN A DRY POWDER INHALATION FORMULATION
    Kamada, Makoto
    Tanimoto, Mitsuhide
    Ito, Atsutoshi
    Kumon, Michiko
    Inoue, Kazuhiro
    Yada, Shuichi
    Minami, Hidemi
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2017, 30 (04) : A8 - A8
  • [3] CO-SPRAY-DRIED MANNITOL WITH POLYETHYLENE GLYCOL FOR DRY POWDER INHALATION: FACTORS AFFECTING THE POLYMORPHISM AND STABILITY
    Kumon, Michiko
    Tanimoto, Mitsuhide
    Ito, Atsutoshi
    Yano, Hideki
    Inoue, Kazuhiro
    Yada, Shuichi
    Minami, Hidemi
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2015, 28 (04) : A10 - A11
  • [4] DEVELOPMENT OF NSAID-CONTAINING DRY POWDER INHALATION FORMULATION CO-SPRAY-DRIED WITH SODIUM STEARATE
    Benke, Edit
    Szabo-Revesz, Piroska
    Ambrus, Rita
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2021, 34 (03) : A17 - A18
  • [5] Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers
    Stass, Heino
    Nagelschmitz, Johannes
    Kappeler, Dominik
    Sommerer, Knut
    Kietzig, Claudius
    Weimann, Boris
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2017, 30 (01) : 53 - 63
  • [6] EFFECT OF SPRAY DRIED FORMULATION ON THE AEROSOL PERFORMANCE OF A NOVEL DRY POWDER INHALER
    Bonasera, Serena
    Farkas, Dale R.
    Longest, P. Worth
    Beverlin, Bryce, II
    Hindle, Michael
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2019, 32 (02) : A10 - A11
  • [7] CO-SPRAY-DRIED MANNITOL WITH POLYETHYLENE GLYCOL (PEG) FOR DRY POWDER INHALATION -THE EFFECT OF PEG ON THE AEROSOLIZATION PERFORMANCE AND THE PHYSICAL STABILITY
    Tanimoto, Mitsuhide
    Ito, Atsutoshi
    Kumon, Michiko
    Inoue, Kazuhiro
    Yada, Shuichi
    Minami, Hidemi
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2016, 29 (03) : A7 - A8
  • [8] Towards a More Desirable Dry Powder Inhaler Formulation: Large Spray-Dried Mannitol Microspheres Outperform Small Microspheres
    Waseem Kaialy
    Tariq Hussain
    Amjad Alhalaweh
    Ali Nokhodchi
    Pharmaceutical Research, 2014, 31 : 60 - 76
  • [9] Towards a More Desirable Dry Powder Inhaler Formulation: Large Spray-Dried Mannitol Microspheres Outperform Small Microspheres
    Kaialy, Waseem
    Hussain, Tariq
    Alhalaweh, Amjad
    Nokhodchi, Ali
    PHARMACEUTICAL RESEARCH, 2014, 31 (01) : 60 - 76
  • [10] DEVELOPMENT OF A SPRAY DRIED TACROLIMUS FORMULATION SUITABLE FOR DELIVERY VIA A DRY POWDER INHALER
    Davidson, Iain G.
    Dey, Fiona
    Western, Karen
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2014, 27 (04) : A12 - A12